A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use

NCT02922543 · clinicaltrials.gov ↗
COMPLETED
Status
361
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Celgene